Huijun Chen

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Venous Thromboembolism

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Huijun Chen, Kensei Hashizume, Friederike Kanefendt, Christine Brase, Sebastian Schmitz, Tianxing Liu
Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data. Clinical and translational science 17 (8) (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Huijun Chen, Kensei Hashizume, Friederike Kanefendt, Christine Brase, Sebastian Schmitz, Tianxing Liu
Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data. Clinical and translational science 17 (8) (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
Yuejie Chen, Yipshu Pui, Huijun Chen, Shan Wang, Peter Serno, Wouter Tonnis, Linc Chen, Feng Qian
Correction to "Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment". Molecular pharmaceutics 16 (4) (2019)